ChromaDex Corp. is devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients, led by our direct to consumer supplement, TRU NIAGEN®.

ChromaDex

Pharmaceutical

United States of America

The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The pharmaceutical industry is developing at an unusually rapid pace. The market for pharmaceuticals is growing persistently, and expenses for drugs will amount to $1.5 trillion globally by 2021. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. Investments in biopharmaceutical innovation are driving contributions to the American economy and solidifying America’s role as a leader in medical innovation. The pharmaceuticals sector is forecasted to grow faster than any other market in the next five years with an emphasis on R&D.

Irvine

California

Los Angeles

51-200 Employees

Dr Charles Brenner discovered nicotinamide riboside as a precursor to NAD+. Learn more about the importance of NAD+ and ...

Dr Brenner explains his discovery of Nicotinamide Riboside as a precursor to NAD

ChromaDex has a collective star rating of 3.1 out of 5 from anonymous employee reviews. While some employees appreciate the work environment and career development opportunities, others express concerns about management quality and work-life balance. Overall, employees seem to have a mixed experience at ChromaDex, with both positive and negative aspects to consider.

ChromaDex

#1 Video-Talent Marketplace

Ready to discover your perfect career?